The methodology matters to people as much as organizations, because secure, content, productive individuals are the lifeblood of any successful business, and such people often elevate the happiness ...

One key benefit is the reduction of triglycerides, a fat found in the blood considered a risk factor for cardiovascular disease. One of the most celebrated benefits of a low-carb diet is its potential ...

The partnership between ATLATL Scientific and Miltenyi Biotec represents a testament to the power of collaboration in driving scientific innovation. ATLATL Scientific and Miltenyi Biotec are ...

Interventions to create a new, independent Board of Cardiovascular Medicine under the American Board of Medical Specialties (ABMS) are closer to becoming a reality with the creation of a formal Board ...

Today's launch expands the LV Edge portfolio, allowing therapeutic developers to choose between an off-the-shelf single plasmid packaging system they can use in their own lab, or a plasmid free cell ...

AUGX), a leader in ambient AI medical documentation and data solutions, today announced the general availability of Augmedix Go for emergency departments (EDs), marking the launch of the industry's ...

As a testament to Turkey's legacy in the world of aesthetic medicine, VeraClinic invites you to discover the transformative power of our hair transplantation and cosmetic surgery services.

In February of 2023, Coya announced results from a proof-of-concept, open-label clinical study evaluating commercially available LD IL-2 and CTLA-4 Ig in a small cohort of patients with ALS conducted ...

We, and the clinicians at the bedside, are eager to see inhaled sedation available also in the US”, said Christopher Hughes, Professor of Anesthesiology at Vanderbilt University Medical Center and ...

Although vehicles may have features such as blind-spot monitors and automatic braking, reaction times are everything when it comes to staying safe on the road… and these can be significantly affected ...

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer ...

As global crypto industry standards say, disadvantages of such countries include the high cost of registration and the cost of maintaining companies, associated, among other things, with the real ...